ChatGPT and BCI-VR: a new integrated diagnostic and therapeutic perspective for the accurate diagnosis and personalized treatment of mild cognitive impairment
The large language model, ChatGPT (OpenAI, 2024), launched by OpenAI on November 30, 2022, rapidly propelled it into the world's fastest-growing consumer software applications, attracting over a hundred million users. This milestone not only marks a significant achievement in artificial intelli...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media SA
2024
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/111502/1/fnhum-18-1426055.pdf http://psasir.upm.edu.my/id/eprint/111502/ https://www.frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2024.1426055/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The large language model, ChatGPT (OpenAI, 2024), launched by OpenAI on November 30, 2022, rapidly propelled it into the world's fastest-growing consumer software applications, attracting over a hundred million users. This milestone not only marks a significant achievement in artificial intelligence (AI) but also has sparked widespread global interest in the potential applications of AI, particularly in the medical domain (Biswas, 2023; Wójcik et al., 2023). Especially in areas such as diagnostic assistance, treatment planning and recommendations, clinical practice and guidelines, clinical research and data analysis, telemedicine, and medical resource allocation (Ferdush et al., 2023), ChatGPT has shown immense potential.
The accurate diagnosis and effective treatment of Mild Cognitive Impairment (MCI) are fraught with numerous challenges, including the high costs and invasive nature of traditional diagnostic methods, side effects associated with treatment plans, and the limitations of resources and time for non-pharmacological interventions (Aniwattanapong, 2021; Reynolds et al., 2021). Given these challenges, improving the accuracy and efficiency of MCI diagnoses and optimizing patient treatment plans have emerged as crucial issues needing resolution in this field.
Simultaneously, the rapid advancement of Brain-Computer Interface (BCI) and Virtual Reality (VR) technologies offers new avenues for addressing these issues. These technologies not only make the diagnostic and treatment processes more convenient and intelligent but also enable BCI-VR-based diagnostic and therapeutic technologies to provide more rapid and accessible methods of diagnosis and assessment for patients with cognitive impairments (Lee et al., 2013).
This paper explores how BCI-VR technologies and ChatGPT can be integrated within medical applications, aiming to propose a comprehensive diagnostic and treatment framework specifically designed for patients with cognitive impairments. By integrating BCI, VR, and ChatGPT, this platform not only seeks to provide patients with new pathways for remote diagnostics, treatment, and follow-up visits but also aims to establish a scientific and systematic framework for comprehensively evaluating the benefits, potential risks, and challenges inherent in technological integration, paving the way for future advances in the diagnosis and treatment of cognitive impairments. |
|---|